Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-415-5 | CAS number: 26021-57-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 19.5.94 to 25.8.94
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 17th July 1992
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The LLNA method was not available yet by the time the study was conducted
Test material
- Reference substance name:
- 3,4-dihydro-2H-1,4-benzoxazin-6-ol
- EC Number:
- 247-415-5
- EC Name:
- 3,4-dihydro-2H-1,4-benzoxazin-6-ol
- Cas Number:
- 26021-57-8
- Molecular formula:
- C8H9NO2
- IUPAC Name:
- 3,4-dihydro-2H-1,4-benzoxazin-6-ol
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source (i.e. manufacturer or supplier) and lot/batch number of test material: hydroxybenzomorpholine (A025) 2484. batch number: 0508918
- Purity, including information on contaminants, isomers, etc.:98.3%
- expiry date : september 2005
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at + 4°C, protected from light and under nitrogen gas
- Stability and homogeneity of the test material in the vehicle/solvent under test conditions (e.g. in the exposure medium) and during storage: no data
- Stability in the medium, i.e. sensitivity of the test material to hydrolysis and/or photolysis: no data
- Solubility and stability of the test material in the solvent/vehicle and the exposure medium: the test item was prepared at the concentration of 2% (w/w) in the vehicle. Before preparation, the vehicle was degassed by sonication for at least 15 minutes and then saturated with nitrogen gas, and kept under nitrogen atmosphere and were stored protected from light (using a glass beaker covered with aluminium foil) and under nitrogen atmosphere before use. they were used within the 6 hours following the preparation according to the known stability results.
The ph of the dosage form, measured at CIT, was approximately 7.5.2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Remarks:
- species recommended by the international regulations for sensitization studies. The strain used has been shown to produce a satisfactory sensitization response using known positive sensitizers
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: breeder - centre d'élevage lebeau, 78950 Gambais, France
- Females (if applicable) nulliparous and non-pregnant: not specified
- Microbiological status of animals, when known: no
- Age at study initiation: not specified
- Weight at study initiation: mean body weight 352 +/- 21 g
- Housing: on day 1, the animals were weighed and randomly allocated to 2 groups : a control group 1 consisting of 5 females and a treated group 2 consisting of 10 females. During acclimatizaion period, throughout the study, the animals were housed individually in polycarbonate cages (48x27x20) equipped with a polypropylene bottle. Sifted and dusted sawdust was provided as litter (SICSA, 92142 Alfortville, France). An analysis of potential residues and major contaminants is performed periodically (Laboratoire Wolff, 92110 Clichy, France)
- Diet (e.g. ad libitum): during the study the animals had free access to "guinea pig sustenance reference 106 diet" (U.A.R., 91360 VILLEMOISSON-sur-Orge, France). Food was periodically analysed (composition and contaminants) by the supplier.
- Water (e.g. ad libitum): drinking water filtered by a F.G. millipore membrane (0.22 micron) was contained in bottles.
- Acclimation period: at least 5 days before the beginning of the study
- Indication of any skin lesions: the animals were identified individually by an ear-tattoo
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 ° C
- Humidity (%): 30 to 70%
- Air changes (per hr): non-recycled and filtered
- Photoperiod (hrs dark / hrs light): 12h/12h
- IN-LIFE DATES: From: 19.05.1994 To: 20.06.1994
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: NaCl 0.9%
- Concentration / amount:
- 6 intradermal injections were made into a clipper area (4cm x 2cm) in the scapular region, using a needle (diameter: 0.50 x16 mm, Terumo: C.M.L., 77140 Nemours, France) mounted on a 1 mL glass syringe (0.01 mL graduations, record: Carrieri, 7505 Paris, France) . Three injections of 0.1 mL were injected into each side of the animal, as follow:
control group:
- FCA diluted 50% (v/v) with an injectable isotonic solution (NaCl 0.9%),
- vehicle,
- a mixture of 50/50 (w/v) FCA diluted to 50% (v/v) with a sterile isotonic aqueous NaCl solution and the vehicle.
treated group:
- FCA diluted to 50% (v/v) with a sterile isotonic aqueous NaCl solution,
- test substance at a concentration of 1% (w/w) in the vehicle,
- a mixture 50/50 (w/v) of FCA diluted to 50% (v/v) with a sterile isotonic aqueous NaCl solution, and, the test substance at a concentration of 1% (w/w) in the vehicle. - Day(s)/duration:
- day 1
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: NaCl 0.9%
- Concentration / amount:
- On day 7, the scapular area was clipped. As the test substance is shown to be non-irritant after occlusive cutaneous treatment during preliminary test, the animals were treated with 0.5 mL of sodium laurylsulphate (10%) in vaseline to provoke irritation. On day 8, a cutaneous application on the 6 injection areas (4cm x 2 cm) of the scapular region was performed.
control group:
application of 0.5 mL of the vehicle
treated group:
application of 0.5 mL of a non-irritant concentration of the test substance i.e. at 25% (w/w) in the vehicle.
the test substance and the vehicle were prepared on a dry compress (Semes France, 54183 Heillecourt, France), which was then applied to the scapular region and held in place for 48 hours by means of an adhesive hypoallergenic dressing (Laboratoires de pansements et d'hygiène, 21300 Chenove, France) and an adhesive anallergenic waterproof plaster (Laboratoire des Professions Médicales, 92240 Malakoff, France). On removal of the dressing, any residual test substance was removed by means of a compress moistened using water for injections. - Day(s)/duration:
- Day 7-8
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: NaCl
- Concentration / amount:
- Maximum Non Irritant Concentration (MNIC) 25%in the vehicle.
The animals form both groups received an application of 0.5 mL of the MNIC of test substance on the posteriori right flank, and 0.5 mL of the vehicle on the posterior left flank. This application was performed using a 1mL plastic syringe (0.01 mL graduations, Terumo: CML, 77140 Nemours, France) . The test substance and vehicle were prepared on a dry compress , the applied to a 4 cm² clipped area of the skin. The compress was held in contact with the skin for 24 hours by means of an occlusive, hypoallergenic dressing and an adhesive anallergenic waterproof plaster. On removal of the dressing, any residual test substance was removed by means of a compress moistened using water for injections. - Day(s)/duration:
- day 22
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Preliminary study: 2 animals
Main study: 5 animals in control group and 10 animals in treated group - Details on study design:
- RANGE FINDING TESTS:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: on day 1, 6 intradermal injections were made into a clipped area (4 cm x 2 cm) in the scapular region, using a needle (diameter: 0.50 x 16 mm, Terumo: C.M.L., 77140 Nemours, France) mounted on a 1 mL glass syringe
(0.01 mL graduations, record : carrieri, 75005 Paris, France).
Three injections of 0.1 mL were injected into each side of the animal, as follows:
control group :
- Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic aqueous Na Cl solution and the vehicle
- vehicle
- a mixture of 50/50 (w/v) Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic aqueous NaCl solution and the vehicle.
treated group
- freund's complete adjuvant diluted to 50% (v/v) with a sterile aqueous Na Cl solution
- test substance at a concentration of 1% (w/w) in the vehicle
- a mixture 50/50 (w/v) Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic aqueous NaCl solution, and, the test substance at a concentration of 1% (w/w) in the vehicle.
On day 7, the scapular area was clipped. As the test substance is shown to be non-irritant after occlusive cutaneous treatment during preliminary test, the animals were treated with 0.5 mL of sodium laurylsulphate (10%) in vaseline to provoke irritation. On day 8, a cutaneous application on the 6 injection areas (4cm x 2 cm) of the scapular region was performed.
control group:
application of 0.5 mL of the vehicle
treated group:
application of 0.5 mL of a non-irritant concentration of the test substance i.e. at 25% (w/w) in the vehicle.
the test substance and the vehicle were prepared on a dry compress (Semes France, 54183 Heillecourt, France), which was then applied to the scapular region and held in place for 48 hours by means of an adhesive hypoallergenic dressing (Laboratoires de pansements et d'hygiène, 21300 Chenove, France) and an adhesive anallergenic waterproof plaster (Laboratoire des Professions Médicales, 92240 Malakoff, France). On removal of the dressing, any residual test substance was removed by means of a compress moistened using water for injections.
one hour after removal of the occlusive dressing, cutaneous reactions were recorded.
- Site: for all animals and before each treatment, the application sites were clipped on days -1 and 7 (scapular area 4 cm x 2 cm), clipped again and shaved on da 21 (each flank 2 cm x 2 cm).
B. CHALLENGE EXPOSURE
At the end of the rest period on day 22, the test substance was applied at the Maximum Non Irritant Concentration (M.N.I.C.) at a concentration of 25% (w/w) in the vehicle.
The animals from both groups received an application of 0.5 mL of the MNIC of test substance on the posteriori right flank, and 0.5 mL of the vehicle on the posterior left flank. This application was performed using a 1mL plastic syringe (0.01 mL graduations, Terumo: CML, 77140 Nemours, France) . The test substance and vehicle were prepared on a dry compress , the applied to a 4 cm² clipped area of the skin. The compress was held in contact with the skin for 24 hours by means of an occlusive, hypoallergenic dressing and an adhesive anallergenic waterproof plaster. On removal of the dressing, any residual test substance was removed by means of a compress moistened using water for injections. - Challenge controls:
- control group received the test substance on day 22 at the concentration of 25%
- Positive control substance(s):
- yes
- Remarks:
- the sensitivity of Dunkin-Hartley guinea-pigs to a positive control dinitro 2,4 chlorobenzene was checked in January 1994 on 5 female at a concentration of 0.5%. it induced a positive skin sensitization reactions in 100% of the guinea pigs.
Results and discussion
- Positive control results:
- the sensitivity of Dunkin-Hartley guinea-pigs to a positive control dinitro 2,4 chlorobenzene was checked in January 1994 on 5 female at a concentration of 0.5%. it induced a positive skin sensitization reactions in 100% of the guinea pigs.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 0.05%
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- erythema, dryness of the skin
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- positive control
- Dose level:
- 0.05%
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- erythema, dryness of the skin, crust
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- beige coloration of the skin in 10 animals
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- beige coloration of the skin in 4 animals
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- beige coloration of the skin in 3 animals
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- beige coloration of the skin in 3 animals
Any other information on results incl. tables
Individual body weight values (g)
|
|
|
days |
|||||||
groups |
sex |
animals |
-1 |
1 |
(1) |
8 |
(1) |
15 |
(1) |
25 |
1 |
female |
116 |
342 |
357 |
85 |
442 |
40 |
482 |
89 |
571 |
|
|
117 |
356 |
355 |
4 |
359 |
63 |
422 |
56 |
478 |
|
|
118 |
360 |
367 |
52 |
419 |
62 |
479 |
76 |
555 |
|
|
119 |
372 |
372 |
63 |
435 |
38 |
473 |
53 |
526 |
|
|
120 |
366 |
372 |
65 |
437 |
59 |
496 |
46 |
542 |
|
|
M |
359 |
365 |
54 |
418 |
52 |
470 |
64 |
534 |
|
|
SD |
11 |
8 |
30 |
34 |
12 |
28 |
18 |
36 |
2 |
female |
121 |
313 |
323 |
62 |
385 |
46 |
431 |
61 |
492 |
|
|
122 |
344 |
343 |
72 |
415 |
49 |
464 |
-9 |
455 |
|
|
123 |
319 |
320 |
73 |
393 |
72 |
465 |
49 |
514 |
|
|
124 |
320 |
309 |
31 |
340 |
52 |
392 |
48 |
440 |
|
|
125 |
355 |
365 |
72 |
437 |
64 |
501 |
54 |
555 |
|
|
126 |
348 |
343 |
57 |
400 |
60 |
460 |
54 |
514 |
|
|
127 |
326 |
321 |
67 |
388 |
44 |
432 |
64 |
496 |
|
|
128 |
334 |
341 |
52 |
393 |
63 |
456 |
80 |
536 |
|
|
129 |
363 |
354 |
71 |
425 |
32 |
457 |
93 |
550 |
|
|
130 |
358 |
350 |
64 |
414 |
45 |
459 |
53 |
512 |
|
|
M |
338 |
337 |
62 |
399 |
53 |
452 |
55 |
506 |
|
|
SD |
18 |
18 |
13 |
27 |
12 |
28 |
27 |
37 |
(1) = body weight gain
M = mean
SD = Standard Deviation
Macroscopic examination of cutaneous reactions – challenge application
|
|
|
Day 24 scoring period (after 24 hours) |
Day 25 scoring period (after 48 hours) |
||||||
|
|
|
Erythema |
Oedema |
Erythema |
Oedema |
||||
Group |
Sex |
Animals |
LF |
RF |
LF |
RF |
LF |
RF |
LF |
RF |
Control 1 |
Female |
116 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
|
|
117 |
0 |
0 |
0 |
0 |
0 |
|
0 |
0 |
|
|
118 |
0 |
0 |
0 |
0 |
0 |
|
0 |
0 |
|
|
119 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
|
|
120 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
Treated 2 |
Female |
121 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
122 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
123 |
0 |
0/C |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
124 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
125 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
|
|
126 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
127 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
|
|
128 |
0 |
0/C |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
129 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
|
|
130 |
0 |
0/C |
0 |
0 |
0 |
0/C |
0 |
0 |
LF : left flank (control)
RF : right flank (treated)
C : beige colouration of the skin
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the present study, hydroxybenzomorpholine was non-sensitising.
- Executive summary:
The dilutions of IMEXINE OV used were selected on the basis of the results from preliminary
intra-dermal and topical experiments in which:
• 1% (w/w) hydroxybenzomorpholine in paraffin oil was the maximum practicable
concentration for intra-dermal injection; only slight irritation was observed at this
concentration;
• 25% (w/w) hydroxybenzomorpholine in paraffin oil was the maximum practicable
concentration for topical induction and challenge and it did not provoke any signs of irritation.The application sites were clipped free of fur before each induction or challenge treatment. The induction procedure consisted of intra-dermal injections and one topical application, 7-day apart.
On a day designated as day 1, the animals received 3 pairs of intra-dermal injections in the scapular area, consisting of:
• 50% (v/v) Freund’s Complete Adjuvant in physiological saline (FCA, control and treated animals)
• hydroxybenzomorpholine at 0% or 1% (w/w) in paraffin oil (control and treated animals, respectively)
• a 50/50 (w/v) mixture of FCA and 0% or 1% hydroxybenzomorpholine (w/w) in paraffin oil (control and treated animals, respectively)
As hydroxybenzomorpholine at 25% (w/w) in paraffin oil (maximum practicable concentration) was non-irritating, the animals were treated on day 7 with 0.5 ml sodium lauryl sulphate in petrolatum (10%) to elicit local irritation. On day 8, 0.5 ml of hydroxybenzomorpholine at 0 or 25% (w/w) in paraffin oil was prepared on a dry compress and applied over the intra-dermal injection sites in control and treated animals, respectively. The compress was held under occlusion for 48 hours by means of surgical tape and elastic adhesive bandage (topical induction). Two weeks after the topical induction (day 22), 0.5 ml of hydroxybenzomorpholine
at 0 or 25% (w/w) in paraffin oil was prepared on a dry compress and applied to a 4 cm2 area to all control and treated animals on their left and right flanks, respectively (challenge topical application). These patches were kept for 24 hours under occlusion. The animals were examined and cutaneous reactions were assessed 24 and 48 hours after dressing removal.
Results
No skin reactions were observed at the vehicle (paraffin oil) or hydroxybenzomorpholine challenge application sites in control or treated animals, at any examination time-point.Conclusion
Under the conditions of the present study, hydroxybenzomorpholine was non-sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.